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OBJECTIVE — The aim of this study was to develop a partial closed-loop system to safely
preventnocturnalhypoglycemiabysuspendinginsulindeliverywhenhypoglycemiaispredicted
in type 1 diabetes.
RESEARCH DESIGN AND METHODS — Forty subjects with type 1 diabetes (age
range 12–39 years) were studied overnight in the hospital. For the ﬁrst 14 subjects, hypoglyce-
mia(60mg/dl)wasinducedbygraduallyincreasingthebasalinsulininfusionrate(withoutthe
use of pump shutoff algorithms). During the subsequent 26 patient studies, pump shutoff
occurred when either three of ﬁve (n  10) or two of ﬁve (n  16) algorithms predicted
hypoglycemia based on the glucose levels measured with the FreeStyle Navigator (Abbott Dia-
betes Care).
RESULTS — The standardized protocol induced hypoglycemia on 13 (93%) of the 14 nights.
With use of a voting scheme that required three algorithms to trigger insulin pump suspension,
nocturnal hypoglycemia was prevented during 6 (60%) of 10 nights. When the voting scheme
was changed to require only two algorithms to predict hypoglycemia to trigger pump suspen-
sion, hypoglycemia was prevented during 12 (75%) of 16 nights. In the latter study, there were
25predictionsofhypoglycemiabecausesomesubjectshadmultiplehypoglycemiceventsduring
a night, and hypoglycemia was prevented for 84% of these events.
CONCLUSIONS — Using algorithms to shut off the insulin pump when hypoglycemia is
predicted,itispossibletopreventhypoglycemiaon75%ofnights(84%ofevents)whenitwould
otherwise be predicted to occur.
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C
ontinuous glucose monitoring
(CGM) represents the “third era” in
diabetes management after the eras
of urine glucose testing and (self-
monitoring)bloodglucosetesting.Oneof
the important potential beneﬁts of real-
timeCGMistheabilityofthesedevicesto
alarm for hypoglycemia. However, a pre-
viousstudyshowedthat71%ofyouthdid
not respond to hypoglycemia alarms dur-
ing the night (1). Moreover, the most se-
vere hypoglycemic events in the Diabetes
Control and Complications Trial oc-
curred during sleep hours (2). Davis et al.
(3) found that 75% of hypoglycemic sei-
zures in children occurred during sleep.
Sovik and Thordarson (4) reported that
among patients aged 40 years who died
over a 10-year period, 6% of the deaths
were due to “dead-in-bed” syndrome,
which in many instances was probably the
result of severe nocturnal hypoglycemia.
The availability of CGM systems has
alloweddeterminationoftheincidenceof
nocturnal hypoglycemia in the home en-
vironment. In a randomized trial evaluat-
ing daily CGM use over a 6-month period
in children and adults with type 1 diabe-
tes, 216 subjects used a CGM device for a
total of 25,473 nights (5). The glucose
level was 70 mg/dl on 25% of nights,
60 mg/dl on 15% of nights, and 50
mg/dl on 8% of nights (5) (C. Kollman,
unpublisheddata).Similarorevenhigher
frequencies of nocturnal biochemical hy-
poglycemia have been found in other
studies (6–9).
Inapreviousreport,weprospectively
studied the prevention of daytime hypo-
glycemia using CGM, hypoglycemia pre-
diction algorithms, and temporary
discontinuation of insulin via continuous
subcutaneous insulin infusion (insulin
pump) (10). Hypoglycemia was pre-
vented using a 90-min pump suspension
on 60–80% of days. Cengiz et al. (11)
described automatic pump suspension
using the proportional integral derivative
algorithm during 34 h of closed-loop au-
tomated insulin delivery in 17 patients.
They were successful in preventing hypo-
glycemia(glucose60mg/dl)in14of18
(78%) suspension episodes. The purpose
of the present study was to extend our
original observations to evaluate the pre-
vention of nocturnal hypoglycemia using
hypoglycemia prediction algorithms.
RESEARCH DESIGN AND
METHODS— Subjects for this study
wererecruitedattheBarbaraDavisCenter
(Aurora, CO) and the Stanford Medical
Center (Stanford, CA). The protocol was
approved by the local institutional review
boards, and all subjects and parents or
guardians signed an informed consent
formandanassentformifnecessary.Sub-
jects in this study had had type 1 diabetes
for at least 1 year and had used a down-
loadable insulin pump for at least 3
months.
Participants were trained on the use
of the FreeStyle Navigator CGM system
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were instructed to wear two systems for
each study. The two CGM systems were
usually inserted 1–2 days before admis-
sion. Subjects arrived at the Clinical
Translational Research Center (CTRC) at
7:30 P.M. after a dinner consisting of
knownamountsofcarbohydrate,protein,
and fat.
Inducing nocturnal hypoglycemia
Fourteen subjects completed the control
(hypoglycemia induction) visit at the
CTRC with the intent to establish a con-
sistentmethodforinducingnocturnalhy-
poglycemia using increases in basal
insulin. After admission to the CTRC and
stabilization, basal insulin was increased
in 5–25% increments every 90 min, de-
pendingonthecurrentbloodglucose,the
glucose rate of change, and the linearly
predicted glucose value to be reached by
5:00 A.M. (aim 60 mg/dl). The subject’s
blood glucose was monitored every
15–30minusingtheFreeStylemeterbuilt
intotheNavigator(theonlymeterusedin
this study). Blood was also collected for
YSI(YellowSprings,OH)glucoseanalysis
once theFreeStyle reading was 70 mg/dl.
When the hypoglycemic threshold was
reached (blood glucose value 60 mg/
dl), oral carbohydrates were given to re-
turn glucose levels to 70 mg/dl.
Preventing hypoglycemia
The same consistent method for inducing
hypoglycemiawasusedinthesubsequent
studies to assess whether hypoglycemia
prediction and insulin pump suspension
could prevent nocturnal hypoglycemia.
The Navigator glucose alarms, including
the built-in Projected Low Alarm, were
not activated during the study. For the
hypoglycemia prevention studies, one of
the Navigator sensors was connected to a
laptop computer containing the artiﬁcial
pancreas system (12) and the hypoglyce-
mia prediction algorithm (13) composed
of ﬁve separate prediction algorithms and
a voting schema, explained brieﬂy in the
following.
1. Modiﬁed linear prediction alarm. This
alarm uses a 15-min linear extrapola-
tion and an uncertainty threshold
based on the SD of the glucose mea-
surements in the previous 15 min.
2. Kalman ﬁltering. A Kalman ﬁlter is
used to obtain an estimate of glucose
and its rate of change, which are then
usedtomakepredictionsoffutureglu-
cose levels. The ﬁlter is tuned to
choose between the probabilities that
a measured glucose change is real ver-
sus the result of signal noise (14).
3. Adaptive hybrid inﬁnite impulse re-
sponse (HIIR) ﬁlter. An inﬁnite impulse
responseﬁlterupdatesparametersadap-
tively using the CGM signal. The HIIR
ﬁlter considers a bandwidth of past data
to update the ﬁlter parameters.
4. Statistical prediction. Multiple em-
pirical, statistical models are used to
estimate future glucose values and
their error bounds. A probability of
hypoglycemia is generated and
thresholded to produce an alarm (15).
5. Numerical logical algorithm. The al-
gorithm transmits a three-point cal-
culated rate of change and the
current value into logical expres-
sions to detect impending hypoglyce-
mia. The numerical logical algorithm
provides insensitivity to sensor signal
dropouts.
The algorithms for pump suspension
were based on a 35-min prediction hori-
zon(looking35minintothefuture)anda
glucose threshold of 80 mg/dl. The glu-
cosethresholdand35-minpredictionho-
rizon were chosen to allow time for the
pump suspension to be effective in low-
eringinsulinlevelsoncethebasalratewas
suspended and was based on analysis of
previous CGM data with nocturnal hypo-
glycemia. There is a sustained negative
rate of change in glucose levels lasting a
mean of 75 min after insulin pump sus-
pension (10). In our initial 10 patient
studies we required three of the hypogly-
cemia prediction algorithms to be simul-
taneously positive twice in a 10-min
windowbeforethepumpwassuspended.
In the subsequent 16 studies we only re-
quired two alarms to be simultaneously
positivetwiceina10-minwindow.When
the hypoglycemia prediction algorithm
alarmed (on a computer outside the sub-
ject’s room), study staff manually sus-
pended insulin delivery from the pump
using a 90-min suspend protocol. Serum
ketone levels were measured at the pump
suspension, after insulin restart, and each
morningoncompletionofthestudyusing
the Precision Xtra meter (Abbott Diabetes
Care).
Criteria for restarting insulin
infusion
The initial protocol involved a 90-min
pump suspension when hypoglycemia
was predicted. Because there were often
multiple hypoglycemia events predicted
eachnight,itwasdesiredtolimitthetime
insulin was suspended once the glucose
was past the nadir. Thus, for the ﬁnal 11
subjects,thecriteriaforrestartingapump
suspension included 1) a minimum of 30
min of pump suspension, 2) a positive
rate of change on the FreeStyle Navigator
system of 0.5 mg/dl-min, and 3) a Free-
Style Navigator glucose value 80 mg/dl.
Whenbasalinsulinwasrestarted,itwasat
the subject’s usual rate for that time of
night.
RESULTS
Inducing nocturnal hypoglycemia
Fourteen subjects, aged 12–39 years,
were initially studied for the induction of
nocturnal hypoglycemia in the CTRC.
Many of these same subjects participated
in the subsequent two hypoglycemia pre-
vention protocols. The demographic in-
formation for subjects participating in
eachofthethreestudiesisshowninTable
1.Theﬁrststudywasdesignedtodevelop
a reliable method of producing nocturnal
hypoglycemia (80% success) and the
second and third studies were designed
to study the possibility of preventing
nocturnal hypoglycemia using predic-
tive algorithms and temporary insulin
suspension.
With use of the protocol to generate
nocturnal hypoglycemia, 13 of the 14
subjects (93%) reached glucose levels
60mg/dl;9of14hadlevels55mg/dl.
Table 1—Demographic information
Study to induce
hypoglycemia
Pump shutoff requiring
three predictions
Pump shutoff requiring
two predictions
Age (years) 21.0  7.5 22.5  6.3 22.0  8.9
Duration of type 1
diabetes (years) 12.1  6.0 12.7  5.5 11.5  6.9
A1C (%) 7.8  1.9 7.3  0.8 7.3  0.7
BMI (kg/m
2) 22.0  3.1 24.6  2.8 25.2  3.9
Data are means  SD.
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180%. There were no seizures or loss of
consciousness.
Preventing hypoglycemia
Twenty-six subjects participated in this
phase of the study. A hypoglycemia
threshold of 80 mg/dl and a prediction
horizon(thetimethealgorithmislooking
into the future to predict hypoglycemia)
of 35 min was used for this study. For the
ﬁrst 10 patient studies, the insulin pump
shutoff occurred when three algorithms
predicted hypoglycemia and for the last
16 patient studies only two of ﬁve predic-
tion algorithms were required to shut off
the pump. During the study with the ﬁrst
10 subjects, hypoglycemia was prevented
on 6 (60%) of the 10 nights. There were a
totalof15hypoglycemiceventspredicted
during these 10 nights (three subjects
having two events and one subject having
three events), and hypoglycemia was pre-
vented for 71% of the events (Table 2).
When we assessed the time between
two hypoglycemia prediction algorithms
voting to turn off the pump and three al-
gorithms voting to turn off the pump,
therewasameandifferenceof12min.To
provide more time for the pump shutoff
to be effective, we therefore conducted
our next set of studies with the require-
ment of only two of the ﬁve algorithms to
predict hypoglycemia to trigger pump
suspension. This resulted in hypoglyce-
mia being prevented on 12 of 16 nights
(75%) (Table 2). Four subjects had two
events during the night, one subject had
three events, and one subject had four
events. For the 25 hypoglycemic events,
hypoglycemia was prevented 84% of the
time. Figure 1 illustrates successful pre-
vention of hypoglycemia using two insu-
lin suspensions during the night.
We also evaluated which alarms were
contributingtotheﬁrst,second,andthird
votes to turn the pump off (Table 3). The
linear prediction algorithm was the least
likely to predict hypoglycemia. Other-
wise, all of the algorithms played a signif-
icant role in contributing to the vote.
Factors relating to successful
hypoglycemia prevention
A comparison was done between several
factors that may play a role in the success
of the system. These included the accu-
racy of the FreeStyle Navigator system (a
comparison of the FreeStyle Navigator
system value with the YSI blood glucose
value), the rate of change in the glucose
readings at the time of pump suspension,
and the YSI blood glucose value at the
time of pump suspension. The difference
between the FreeStyle Navigator system
and the YSI glucose values at the time of
pump suspension was 4  9 mg/dl
(mean  SD) for successful events, and
the Navigator was always reading higher
than the YSI when the predictive pump
shutoff failed (mean of 18  10 mg/dl for
failures) (P  0.001). The other factors,
such as rate of glucose change and YSI
glucosevalueatthetimeofpumpshutoff,
were not signiﬁcantly different between
successful and unsuccessful events. The
ﬁrstepisodeofpumpsuspensionwassuc-
cessful 75% of the time, and subsequent
episodesweresuccessful80%ofthetime.
The glucose rate of change was less with
subsequent pump suspensions, because
the basal rate was returned to the usual
infusion rate for that time of night
(meanSDrateofchange0.720.42
mg/dl-min on ﬁrst shutoff and 0.24 
0.13 mg/dl-min on subsequent shutoffs).
Early restart of basal insulin
In the last 11 patient studies, an early re-
start of basal insulin was permitted once
the glucose was past the nadir (see RE-
SEARCH DESIGN AND METHODS).Therewere19
hypoglycemic events on these 11 nights,
and the early pump restart occurred on 5
occasions. The mean peak glucose after
restart of an insulin infusion in the cohort
Figure 1—Successful prevention of hypoglycemia (glucose levels by CGM or venous blood 60
mg/dl)asaresultoftwo90-minperiodsofinsulinpumpsuspension.Thehypoglycemiaprediction
algorithmrequiredtwo(ofﬁve)alarmsforpumpsuspensionandwasbasedona35-minprediction
horizon and a CGM glucose threshold of 80 mg/dl.
Table 2—Results of the three-alarm and two-alarm voting systems
No. predictive algorithms needed
to trigger pump suspension n
Subjects without
hypoglycemia
No.
events*
Events without
hypoglycemia
3 of 5 10 60 15 71
2 of 5 16 75 25 84
Data are % unless indicated otherwise. *An event is an episode of predicted hypoglycemia resulting in a
pump suspension.
Table 3—Distribution of algorithms that
were the ﬁrst, second, or third to predict
hypoglycemia
Alarm
First
alarms
Second
alarms
Third
alarms
Statistical prediction 60 28 6
Numerical logical 30 28 24
HIIR 3 10 49
Kalman 7 31 21
Linear prediction 0 3 0
Data are %.
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149  32 mg/dl, and the maximum glu-
cose was 210 mg/dl. In the nights in
which an early restart of insulin was not
permitted, the mean peak glucose after
pump suspension was 158  50 mg/dl
and the highest glucose was 275 mg/dl.
These differences were not statistically
signiﬁcant.
Occurrence of ketonemia
Four subjects developed ketone levels
0.3 mmol   l
1   l
1 (range 0.4–1.5
mmol   l
1   l
1). In each instance, when
the serum ketone levels were checked
several hours later, they were 0.3 mmol  
l
1   l
1. In two instances, the pump had
been suspended for 90 min (ﬁnal glucose
levels 146 and 155 mg/dl), and in two
instances (with more than one suspen-
sion),thepumphadbeensuspendedfora
total of 180 min (ﬁnal glucose levels 202
and 261 mg/dl). In each case the serum
ketone levels were 0.3 mmol   l
1   l
1
after the ﬁrst suspension. There were no
clinicalsymptomssuchasupsetstomach,
nausea, or Kussmaul respirations, and no
speciﬁc treatment was given.
CONCLUSIONS — Prevention of se-
vere nocturnal hypoglycemic events re-
mainsoneofthemostchallenginggoalsin
the treatment of diabetes. With the pre-
vention of severe hypoglycemia, it is
likely that more people would be able to
move toward optimal glycemic control.
Because of the decrease in counterregula-
tory hormone secretion during sleep,
even in people without diabetes (16), and
the frequent loss of counterregulatory
hormone secretion in people with diabe-
tes (17,18), prevention will probably re-
quire the use of a closed-loop system. In
this initial step toward a closed-loop sys-
tem, we tested the use of a subcutaneous
sensor signal to predict impending hypo-
glycemiaandtotriggerpumpsuspension.
It was not possible to eliminate nocturnal
hypoglycemia completely. However, hy-
poglycemia was prevented during 75% of
the nights and for 84% of predicted
events. Presumably, a hypoglycemia pre-
diction algorithm, as used in the present
study, will be combined with discontinu-
ation of continuous subcutaneous insulin
infusion at a speciﬁc glucose level. The
latter currently occurs in the Medtronic
MiniMed Paradigm Veo Real-Time Sys-
tem in Europe. The two working together
may be very effective in preventing severe
hypoglycemia.
In some cases for which hypoglyce-
mia was not successfully prevented, the
subjects’ sensor glucose values were con-
sistently running higher than the blood
glucosevalues.Thismayhavebeendueto
CGM inaccuracy or due to the known lag
time of 8–10 min between the two
compartments (19). Future investigators
may be able to use a forced CGM calibra-
tionatbedtimeifthereisasigniﬁcantdis-
crepancy between a discrete bedtime
glucose value and the sensor glucose to
minimize this effect. We initially hypoth-
esized that the rate of fall of the glucose
values before a hypoglycemic event
would also be a major factor in determin-
ing the success or failure of hypoglycemia
prevention. However, this did not prove
to be true.
To achieve a high rate of nocturnal
hypoglycemia, we systematically in-
creased nocturnal basal infusion rates
until there was a 80% risk of hypogly-
cemia. Because of receiving higher basal
insulin infusion rates than on a typical
night, subjects probably experienced a
more rapid rate of fall in glucose levels
with a longer residual insulin effect. This
may have made it more difﬁcult for the
pump suspension algorithms to prevent
impendinghypoglycemia.Unfortunately,
even when the basal rate was at the usual
infusionrateforthatsubject(aftertheﬁrst
pump suspension), we still failed to pre-
vent hypoglycemia 20% of the time.
Itisknownthatonceapersonhashad
onehypoglycemicevent,asecondeventis
more likely (17). Thus, overall these re-
sults seem promising.
Although a rigid blood glucose cutoff
of60mg/dlwasusedtodeﬁnefailureof
prevention of hypoglycemia, it is possible
thatwewereoverlycautious.Theshortest
known time of prolonged hypoglycemia
(40 mg/dl while using the Medtronic
ParadigmCGMsystem)beforeaseizureis
currently 2.25 h (20). There were no se-
vere hypoglycemic events in the current
study. It would also be unlikely using the
current protocol that the duration of hy-
poglycemia would be long enough to re-
sult in a severe hypoglycemic episode.
Previous studies have shown that suspen-
sion of insulin delivery for up to2hh a s
not resulted in signiﬁcant ketosis (10,21–
25).Inourstudies,therewasmildketosis
on four occasions when the pump was
suspended for 90–180 min, and in each
instance serum ketone levels returned to
normal with the reinstitution of basal in-
sulin therapy.
Studies in the home setting are now
needed.Theinitialaimwillbetoprevent-
ing nocturnal hypoglycemia, and studies
will be randomized to include nights
when the prevention system is in place
and to include control nights when the
system is not in use. The bedside mini-
computer will randomize the nights and
will also act as an intermediary (contain-
ing the prevention algorithms) between
the insulin pump and the CGM. Studies
will begin with adults but will then be
extended to children. It is our belief that
most episodes of severe nocturnal hypo-
glycemia will be preventable, using either
this or a similar system.
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